Hypoaldosteronism diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
*There is no established criteria for the diagnosis of hypoaldosteronism. However, patients with suspected hypoaldosteronism should be tested for underlying | *There is no established criteria for the diagnosis of hypoaldosteronism. However, patients with suspected hypoaldosteronism should be tested for underlying conditions which can lead to decreased aldiabetes, chronic kidney disease, serum mineralocorticoid, corticosteroid and androgen level. Patients with family history of hypoaldosteronism should also be checked for CYP11B2 and mutations in aldosterone receptor genes. Complete history should be obtained regarding drug use such as NSAID, ACEi, B blockers, heparin, calcineurin inhibitors. | ||
==References== | ==References== | ||
Revision as of 20:14, 18 August 2017
|
Hypoaldosteronism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoaldosteronism diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Hypoaldosteronism diagnostic criteria |
|
Risk calculators and risk factors for Hypoaldosteronism diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established criteria for the diagnosis of hypoaldosteronism.
Diagnostic Criteria
- There is no established criteria for the diagnosis of hypoaldosteronism. However, patients with suspected hypoaldosteronism should be tested for underlying conditions which can lead to decreased aldiabetes, chronic kidney disease, serum mineralocorticoid, corticosteroid and androgen level. Patients with family history of hypoaldosteronism should also be checked for CYP11B2 and mutations in aldosterone receptor genes. Complete history should be obtained regarding drug use such as NSAID, ACEi, B blockers, heparin, calcineurin inhibitors.